轴性脊椎关节炎:目前的进展,未来的挑战
1Schroeder Arthritis Institute, University Health Network and University of Toronto, Toronto, ON, Canada.
Journal of rheumatic diseases
|July 21, 2023
概括
早期发现轴性脊柱关节炎 (axSpA) 对于有效治疗至关重要. 研究强调了肠道微生物群.
科学领域:
- 风湿病学和免疫学
- 遗传学和环境因素
- 微生物组研究 微生物组研究
背景情况:
- 轴性脊柱关节炎 (axSpA) 是一种慢性炎症性疾病,影响年轻人,导致疼痛,疲劳和潜在的脊柱残疾.
- 早期诊断axSpA具有挑战性,但至关重要,因为及时使用生物药物的干预可以改变疾病的进展.
- 遗传和环境因素有助于axSpA的易感性,最近的重点是肠道微生物组的作用.
研究的目的:
- 解决 axSp.A. 早期识别和管理方面的未满足需求.
- 探索 axSpA 中肠关节轴内的免疫连接.
- 为 axSpA.确定新的治疗点.
主要方法:
- 对 axSpA.最近的临床和实验研究的综述.
- 对遗传易感性因素的分析.
- 研究肠道微生物组及其免疫学影响.
主要成果:
- 了解axSpA遗传学和环境影响的进展,包括肠道微生物群.
- 关于肠关节轴的免疫学的新兴见解.
- 确定未来axSpA研究的主要研究领域.
结论:
- 对axSpA.需要改进早期病例识别和敏感生物标志物.
- 了解 axSpA (皮肤,眼睛,肠道) 中的共享炎症途径是必不可少的.
- 针对治疗潜力的新型治疗策略是axSpA研究的优先事项.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
38
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
38
Rheumatic Heart Disease III: Medical Management
20
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
20
Rheumatic Heart Disease I: Introduction
17
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
17


